| 1 |
Saito T, Sato H, Kudo K, et al. Lipoprotein glomerulopathy: glomerular lipoprotein thrombi in a patient with hyperlipoproteinemia [J]. Am J Kidney Dis, 1989, 13(2): 148-153.
|
| 2 |
Saito, Matsunaga A, Ito K．Topics in lipoprotein glomerulopathy: an overview [J]. Clin Exp Nephrol, 2014, 18(2): 214-217.
|
| 3 |
Liao MT, Tsai IJ, Cheng HT, et al. A rare cause of childhood-onset nephrotic syndrome: lipoprotein glomerulopathy [J]. Clin Nephrol, 2012, 78(3): 237-240.
|
| 4 |
王秋媛，罗长青．脂蛋白肾病发病机制研究进展[J]. 国际泌尿系统杂志，2014, 34(3): 415-419.
|
| 5 |
Tsimihodimos V, Elisaf M. Lipoprotein glomerulopathy [J]. Curr Opin Lipidol, 2011, 22(4): 262-269.
|
| 6 |
Matsunaga A, Saito T. Apolipoprotein E mutations: a comparison between lipoprotein glomerulopathy and type Ⅲ hyperlipoproteinemia [J]. Clin Exp Nephrol, 2014, 18(2): 220-224.
|
| 7 |
贺西南，向少伟. 脂蛋白肾病的研究现状[J]. 中国中西医结合肾病杂志，2007，7(8): 433-434.
|
| 8 |
Chen Y. Lipoprotein glomerulopathy in China [J]. Clin Exp Nephrol, 2014, 18(2): 218-219.
|
| 9 |
Yoshida T, Kato K, Yokoi K, et al.Association of gene polymorphisms with chronic kidney disease in high-or low -risk subjects defined by conventional risk factors [J]．Int J Mol Med, 2009, 23(6): 785-792.
|
| 10 |
Oikawa S, Matsunaga A, Saito T, et al. Apolipoprotein E Sendai (arginine 145→proline): a new variant associated with lipoprotein glomerulopathy [J]. J Am Soc Nephrol, 1997, 8(5): 820-823.
|
| 11 |
Hagiwara M, Yamagata K, Matsunaga T, et al. A novel apolipoprotein E mutation, ApoE Tsukuba (Arg 114 Cys), in lipoprotein glomerulopathy [J]. Nephrol Dial Transplant, 2008, 23(1): 381-384.
|
| 12 |
Kinomura M, Sugiyama H, Saito T, et al. A novel variant apolipoprotein E Okayama in a patient with lipoprotein glomerulopathy [J]. Nephrol Dial Transplant, 2008, 23(2): 751-756.
|
| 13 |
Luo B, Huang F, Liu Q, et al. Identification of apolipoprotein E Guangzhou (arginine 150 proline), a new variant associated with lipoprotein glomerulopathy [J]. Am J Nephrol, 2008, 28(2): 347-353.
|
| 14 |
Russi G, Furci L, Leonelli M, et al. Lipoprotein glomerulopathy treated with LDL-apheresis (heparin-induced extracorporeal lipoprotein precipitation system): a case report [J]. J Med Case Rep, 2009, 3: 9311.
|
| 15 |
Bomback AS, Song HD, Agati VD, et al.A new apolipoprotein E mutation, apoE Las Vegas, in a European-American with lipoprotein glomerulopathy [J]．Nephrol Dial Transplant, 2010, 25(10): 3442-3446.
|
| 16 |
Cheung CY, Chan AO, Chan YH, et al. A rare cause of nephrotic syndrome: lipoprotein glomerulopathy [J]. Hong Kong Med J, 2009, 15(1): 57-60.
|
| 17 |
Tokura T, Itano S, Kobayashi S, et al. A novel mutation ApoE2 Kurashiki (R158P) in a patient with lipoprotein glomerulopathy [J]. J Atheroscler Thromb, 2011, 18(6): 536-541.
|
| 18 |
Stratikos E, Chroni A. A possible structural basis behind the pathogenic role of apolipoprotein E hereditary mutations associated with lipoprotein glomerulopathy [J]. Nephrol, 2014, 18(2): 225-229.
|
| 19 |
张祥文，李冰心，贾中尉，等．家族性脂蛋白肾病8例临床分析[J]．广东医学，2012，33(3): 57-58.
|
| 20 |
Hofmann M, Scharnagl H, Panagiotou E, et al.Diminished LDL receptor and high heparin binding of apolipoprotein E2 Sendai associated with lipoprotein glomerulopathy [J]．J Am Soc Nephrol, 2001, 12(3): 524-530.
|
| 21 |
Murano T, Matsumura R, Misawa Y, et al. Interaction of endothelial cells and triglyceride-rich lipoproteins with apolipoprotein E (Arg->Cys) from a patient with lipoprotein glomerulopathy [J]. Metabolism, 2002, 51(2): 201-205.
|
| 22 |
Arai T, Yamashita S, Yamane M, et al.Disappearance of intraglomerular lipoprotein thrombi and marked improvement of nephrotie syndrome by bezafibrate treatment in a patient with lipoprotein glomerulopathy [J]. Atherosclerosis, 2003, 169(2): 293-309.
|
| 23 |
J Kanamaru Y, Nakao A, Shirato I, et al. Chronic graft-versus-host autoimmune disease in Fc receptor gamma chain-deficient mice results in lipoprotein glomerulopathy [J]. J Am Soc Nephrol, 2002, 13(6): 1527-1533.
|
| 24 |
Miyahara Y, Nishimura S, Watanabe M, et al. Scavenger receptor expressions in the kidneys of mice with lipoprotein glomerulopathy [J]. Clin Exp Nephrol, 2012, 16(1): 115-121.
|
| 25 |
Xin Z, Zhihong L, Shijun L, et al. Successful treatment of patients with lipoprotein glomerulopathy by protein A immunoadsorption: a pilot study [J]. Nephrol Dial Transplant, 2009, 24(3): 864-869.
|
| 26 |
Miyata T, Sugiyama S, Nangaku M, et al.Apolipoprotein E2/E5 variants in lipoprotein glomerulopathy recurred in transplanted kidney [J]．J Am Soc Nephrol, 1999, 10(7): 1590-1595.
|
| 27 |
Sam R, Wu H, Yue L, et al.Lipoprotein glomerulopathy: a new apolipoprotein E mutation with enhanced Omenllar binding [J]．Am J Kidney Dis, 2006, 47(3): 539-548.
|
| 28 |
Ogawa T, Maruyama K, Hattori H, et al. A new variant of apolipoprotein E (ApoE Maebashi) in lipoprotein glomerulopathy [J]．Pediatr Nephrol, 2000, 14(2): 149-151.
|
| 29 |
Liao MT, Tsai IJ, Cheng HT, et al. A rare cause of childhood onset nephrotic syndrome: lipoprotein glomerulopathy [J]. Clin Nephrol, 2012, 78(3): 237-740.
|
| 30 |
Magistroni R, Bertolotti M, Furci L, et al. Lipoprotein glomerulopathy associated with a mutation in apolipoprotein e. Clin Med Insights Case Rep, 2013, 6: 189-196.
|
| 31 |
Hu Z, Huang S, Wu Y, etal. Hereditary features, treatment, and prognosis of the lipoprotein glomerulopathy in patients with the APOE Kyoto mutation [J]. Kidney Int, 2014, 85(2): 416-424.
|
| 32 |
Matsunaga A, Furuyama M, Hashimoto T, et al. Improvement of nephrotic syndrome by intensive lipid-lowering therapy in a patient with lipoprotein glomerulopathy [J]. Clin Exp Nephrol, 2009, 13(6): 659-662.
|
| 33 |
杨聚荣，何娅妮，林利容，等. 免疫吸附治疗重症脂蛋白肾病1例报道[J]. 中国血液净化，2006，11(5): 816-818.
|
| 34 |
陈燕，王庆文．全血脂蛋白吸附治疗脂蛋白肾病[J]．肾脏病与透析肾移植杂志，2004，13(5): 493-498.
|
| 35 |
占锦峰，刘志红，李世军，等．免疫吸附治疗脂蛋白肾病的疗效观察[J]．肾脏病与透析肾移植杂志，2006，15: 203-209.
|
| 36 |
陈洁，赵雪红，何海硕，等. 二重滤过血浆置换治疗家族倾向性脂蛋白肾病2例[J]．实用医学杂志，2012，29(10): 930-932.
|
| 37 |
Li W, Wang Y, Han Z, et al. Apolipoprotein e mutation and double filtration plasmapheresis therapy on a new Chinese patient with lipoprotein glomerulopathy [J]. Kidney Blood Press Res, 2014, 39(4): 330-339.
|
| 38 |
陈团营．肾病综合征高脂血症的中医研究进展[J]. 中国医学创新，2011, 8(27): 187-188.
|
| 39 |
许筠．刘宝厚教授对肾病综合征分阶段论治的经验[J]．中国中西医结合肾病杂志，2003, 4(1): 4-5.
|
| 40 |
金玉龙．肾病综合征中西医结合治疗的循证思维方法[J]. 世界中西医结合杂志，2008，3(3): 174-177.
|
| 41 |
晋中恒，郭术莲，蒋松，等．脂蛋白肾病治验2例[J]. 临床合理用药，2013，6(3): 132-133.
|